TransMedics Group (TMDX) Competitors

TransMedics Group (NASDAQ:TMDX) and Smith & Nephew (NYSE:SNN) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their community ranking, risk, media sentiment, valuation, dividends, institutional ownership, analyst recommendations, earnings and profitability.

Which has stronger valuation & earnings, TMDX or SNN?

Smith & Nephew has higher revenue and earnings than TransMedics Group. Smith & Nephew is trading at a lower price-to-earnings ratio than TransMedics Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
TransMedics Group	$488.23M	9.98	-$25.03M	$1.36	105.88
Smith & Nephew	$5.81B	2.28	$263M	$2.16	14.00

Do analysts recommend TMDX or SNN?

TransMedics Group currently has a consensus target price of $125.11, indicating a potential downside of 13.12%. Smith & Nephew has a consensus target price of $28.00, indicating a potential downside of 7.43%. Given Smith & Nephew's higher possible upside, analysts plainly believe Smith & Nephew is more favorable than TransMedics Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
TransMedics Group	0 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.80
Smith & Nephew	0 Sell rating(s)	6 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Does the media prefer TMDX or SNN?

In the previous week, TransMedics Group had 12 more articles in the media than Smith & Nephew. MarketBeat recorded 19 mentions for TransMedics Group and 7 mentions for Smith & Nephew. Smith & Nephew's average media sentiment score of 0.90 beat TransMedics Group's score of 0.54 indicating that Smith & Nephew is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
TransMedics Group	8 Very Positive mention(s)	1 Positive mention(s)	6 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Smith & Nephew	4 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has more volatility and risk, TMDX or SNN?

TransMedics Group has a beta of 2.1, suggesting that its stock price is 110% more volatile than the S&P 500. Comparatively, Smith & Nephew has a beta of 0.68, suggesting that its stock price is 32% less volatile than the S&P 500.

Do insiders and institutionals hold more shares of TMDX or SNN?

99.7% of TransMedics Group shares are held by institutional investors. Comparatively, 25.6% of Smith & Nephew shares are held by institutional investors. 7.0% of TransMedics Group shares are held by company insiders. Comparatively, 1.0% of Smith & Nephew shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Does the MarketBeat Community favor TMDX or SNN?

Smith & Nephew received 333 more outperform votes than TransMedics Group when rated by MarketBeat users. However, 59.18% of users gave TransMedics Group an outperform vote while only 54.10% of users gave Smith & Nephew an outperform vote.

Company	Underperform	Outperform
TransMedics Group	Outperform Votes 116 59.18%	Underperform Votes 80 40.82%
Smith & Nephew	Outperform Votes 449 54.10%	Underperform Votes 381 45.90%

Is TMDX or SNN more profitable?

TransMedics Group has a net margin of 8.14% compared to Smith & Nephew's net margin of 0.00%. TransMedics Group's return on equity of 18.74% beat Smith & Nephew's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
TransMedics Group	8.14%	18.74%	4.39%
Smith & Nephew	N/A	N/A	N/A

Summary

TransMedics Group beats Smith & Nephew on 13 of the 19 factors compared between the two stocks.